Fatty Liver Takes Center StageMedscapeObesity-related fatty liver disease has surpassed other disorders to become the leading cause of chronic liver disease in the United States and a major indication for liver transplantation. Abstract presentations a…
NSF Career Award Allows Development of New BiosensorsLab Manager MagazineWith the five-year, $400,000 award, Singamaneni plans to create a novel class of biosensors based on self-assembled clusters of metal nanoparticles that have been imprinted with a…
The Eight Most Important Organs In The Male BodyDeadspinI like how the airport power outlet tower transforms ordinary business travelers into hippie commune folks who sit Indian style in a circle around the thing. I keep expecting them to hold hands an…
Live coverage: 2-year-old Matthew Ouimet undergoes transplant surgerySan Jose Mercury NewsMatthew Ouimet, 2, of Antioch, is underdoing a 9-hour liver and kidney transplant at 10 a.m Tuesday a UCSF Medical Center Follow reports from reporter Gary Peters…
|
ASCO: Afinitor Quells Herceptin Resistance
MedPage Today In the BOLERO-3 trial, everolimus (Afinitor) significantly extended the time before relapse in patients resistant to trastuzumab (Herceptin), reported Ruth O’Regan, MD, of Emory University in Atlanta. There were also fewer deaths among women treated … |
Relief for Itchy PetsHuffington PostIf your pet is severely itchy and uncomfortable, in some instances, I will prescribe immuno-modulating drugs, like oral steroids or modified cyclosporine. A steroid, like prednisolone, can be given orally once or twi…
Receptive to ReceptosBarron’sFaheem Hasnain, chief executive, previously developed daclizumab for RMS as CEO of Facet, which was acquired by Abbott Laboratories (ABT) in April 2010. Not only does he have a great track record developing multiple scleros…
|
Knome Teams with Omixon to Provide Whole Genome, Exome HLA Typing
GenomeWeb NEW YORK (GenomeWeb News) – Knome has announced that its services division will now offer Omixon’s targeted human leukocyte antigen typing capabilities as part of its whole genome and exome interpretation pipelines. Omixon CEO Attila Berces said … |
URGENT ACTION : STOP VIOLENCE AGAINST PEACUFUL PROTESTORS IN …FIDHWe are deeply concern that there are strong and just claim about brain death of a young person in Ankara because of violence attacks. Moreover, as result of chemical gas attacks and ph…
iatronet.gr |
Το Everolimus καθυστερεί σημαντικά την ανάπτυξη του όγκου στον καρκίνο μαστού
iatronet.gr Στις 2 Ιουνίου 2013, τα αποτελέσματα της κλινικής μελέτης Φάσης ΙΙΙ στον καρκίνο μαστού προχωρημένου σταδίου, BOLERO-3, της εταιρείας Novartis παρουσιάστηκαν στο 49ο Ετήσιο Συνέδριο της Αμερικανικής Εταιρείας Κλινικής Ογκολογίας (ASCO). |